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Abstract
8-Methoxy-γ-humulene, (E)-8-methoxy-β-farnesene, 12-methoxy-β-sesquiphellandrene and 12-methoxyzingiberene can be synthe-
sised in amorphadiene synthase-catalysed reactions from 8- and 12-methoxyfarnesyl diphosphates due to the highly plastic yet
tightly controlled carbocationic chemistry of this sesquiterpene cyclase.
Introduction
Amorphadiene synthase (ADS) from Artemisia annua is a key
enzyme involved in the biosynthesis of the antimalarial
sesquiterpene drug artemisinin (1) [1-4]. ADS catalyses the
Mg2+-dependent conversion of farnesyl diphosphate (FDP, 2) to
amorpha-4,11-diene (3) with high regio- and stereochemical
control (Scheme 1) [5-7]. The carbocationic reaction mecha-
nism of ADS involves an isomerisation to nerolidyl diphos-
phate (NDP, 4) followed by breakage of the carbon–oxygen
bond to generate the allylic cation 5. This allows rotation
around the C2–C3 bond and 1,6-ring closure to form the
bisabolyl cation (6). A [1,3]-hydride shift to form carbocation 7
and 1,10-ring closure yield the amorphyl cation (8). Finally, de-
protonation generates amorpha-4,11-diene (3) [8,9].
Several sesquiterpene synthases including ADS accept FDP an-
alogues containing a variety of heteroatoms and functional
groups to generate unnatural sesquiterpenoids that are not easily
accessible by conventional organic synthesis [10-19]. Creating
novel sesquiterpenoids, not normally found in nature, is of great
interest due to the important applications of terpenoids in
healthcare and agriculture as well as the potential to tailor their
properties to specific needs. For example, fluorinated deriva-
tives of (E)-β-farnesene, a potent alarm pheromone for aphids
[20-23], are more effective as pheromones than the parent com-
pound, and finding high potency derivatives of (E)-β-farnesene
may be of significant benefit in agriculture [24]. While (S)-
germacrene D is a highly volatile but unstable olfactory signal
that repels invertebrate arthropod pests (insects, ticks, mites)
that affect humans and livestock as well as arable crops, (S)-
14,15-dimethylgermacrene D acts as an attractant of aphids
[10]. β-Sesquiphellandrene and α-curcumene are both found in
turmeric (Curcuma longa) and have been shown to have anti-
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Scheme 1: Mechanism of the ADS-catalysed conversion of FDP (2) to amorpha-4,11-diene (3), a biosynthetic precursor of artemisinin (1).
Scheme 2: Synthesis of 8-methoxy-FDP (11) and 12-methoxy-FDP (12) (for full synthesis details see Supporting Information File 1).
cancer activity [25,26]. The oxygenated α-curcumene and
β-sesquiphellandrene derivatives α- and β-turmerone are re-
ported to possess anticonvulsant properties and are used to treat
epilepsy [27,28]. This array of important compounds shows the
potential of generating novel sesquiterpenoids with desirable
bio-properties.
ADS is a high fidelity sesquiterpene synthase that produces
almost exclusively a single product. Its active site plasticity
nevertheless allows the conversion of 12-hydroxy-FDP (9) to
dihydroartemisinic aldehyde (10), a biosynthetic intermediate
and valuable precursor in the synthesis of artemisinin [29].
Results and Discussion
Here we report that ADS accepts the bulkier FDP analogues
8-methoxy-FDP (11) and 12-methoxy FDP (12) as substrates,
thereby opening up direct and efficient synthetic routes to
oxidised sesquiterpenoids. This represents in essence a reversal
of the biosynthetic pathways to oxidised sesquiterpenoids since
cyclisation occurs after FDP ‘oxidation’. 8-Methoxy-FDP (11)
and 12-methoxy-FDP (12) were both prepared in the same
manner, beginning with a tetrahydropyranyl (THP) protection
of (E,E)-farnesol to form 13 [29,30]. This was followed by a
selenium dioxide oxidation that produced 12-hydroxyfarnesol
(14) as the major product (48%, already published in [29]) in
addition to 8-hydroxyfarnesol (15, 11%) [31]. Both of these
alcohols were methylated with methyl iodide to yield 16 and 17
[32]. To produce the final FDP analogues, THP was removed to
generate alcohols 18 and 19, and subsequently diphosphory-
lated via halogenated intermediates (Scheme 2 and Supporting
Information File 1) [33-35].
GC–MS analysis (Figure 1) of the organic soluble products
formed from 8-methoxy FDP (11) through ADS catalysis
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Figure 1: Total-ion chromatogram of the pentane extractable products formed in an incubation of ADS with 8-methoxy-FDP (11). Inset: EI+ Mass
spectra of the eluted compounds 20 and 21.
Figure 2: 1H NMR spectrum (500 MHz, CDCl3) of the 8-methoxy-γ-humulene (20) generated by ADS from 8-methoxy-FDP (11).
revealed the formation of a major sesquiterpenoid of molecular
mass 234 (85%). No organic soluble products were detected
when ADS was omitted from the incubation mixture. This prod-
uct was identified as 8-methoxy-γ-humulene (20) by NMR
spectroscopy and comparison of its 1H NMR spectrum
(Figure 2) with that of 8-oxo-γ-humulene, a natural sesquiter-
penoid isolated from the plant Cineraria fruticulorum [36]. The
signals for H5 (δH = 5.44 ppm, d, JH,H = 16.0 Hz), H6
(δH = 6.06, d, JH,H = 16.0 Hz), H15 (δH = 5.00, bs) and H15’
(δH = 5.02, bs) of 8-oxo-γ-humulene [36] are in agreement with
their corresponding equivalents in 20 (H2 (δH = 5.48, d,
JH,H = 16.0 Hz), H1 (δH = 5.88, d, JH,H = 16.0 Hz), H15
(δH = 4.81, d, JH,H = 2.5 Hz) and H15’ (δH = 4.89, d,
JH,H = 2.5 Hz)). The resonances for the methyl groups at C12
and C13 are also analogous, appearing as singlets at 1.03 ppm
in 8-oxo-γ-humulene and 0.96 and 0.97 ppm in 20. The identity
of the minor product (15%) was confirmed as (E)-8-methoxy-β-
farnesene (21) by GC co-elution and comparison of its mass
spectrum with an authentic sample prepared by exposing (E)-β-
farnesene synthase to diphosphate 11 (Supporting Information
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Scheme 3: Potential mechanisms for the ADS-catalysed conversion of 8-methoxy-FDP (11) to 8-methoxy-γ-humulene (20) and (E)-8-methoxy-β-
farnesene (21).
File 1). Further support for the structure of the minor product
came from the excellent agreement of the diagnostic 1H NMR
signals of 21 (H1 (δH = 5.25, d, JH,H = 17.5 Hz), H1’
(δH = 5.06, d, JH,H = 11.0 Hz), H2 (δH = 6.38, dd, JH,H = 17.5
and 11.0 Hz), H15 (δH = 5.02, s), H15’ (δH = 5.00, s)) with
those reported for the parent sesquiterpene (E)-β-farnesene
(Supporting Information File 1) [37]. The proton on C6
(δH = 5.34, br, t) resonates further downfield for 21 compared
to the corresponding proton of (E)-β-farnesene (δH = 5.17, t,
JH,H = 7.0 Hz) due to the presence of the methoxy group two
carbon atoms away.
The ADS-catalysed 1,11-cyclisation of diphosphate 11 sug-
gests that the 8-methoxy group prevents the formation of a con-
formation conducive to isomerisation to NDP (4, Scheme 1)
and hence 1,6-cyclisation to generate a bisabolyl cation and the
amorphane skeleton. Rather the active site conformations of 11
and cation 22 appear to enable a 1,11-cyclisation to 23.
A subsequent [1,3]-hydride shift to cation 24 and deprotonation
from C15 lead to 8-methoxy-γ-humulene (20, Scheme 3A). Al-
ternatively, the nucleophilic 8-methoxy group could react at
C10 to induce a fast 1,11-cyclisation, forming cation 25, which
effectively competes with the isomerization of 11 to 8-me-
thoxy-NDP. A subsequent [1,3]-hydride shift leads to 24
(Scheme 3A). Direct deprotonation of 22 at C15 forms the
minor reaction product (E)-8-methoxy-β-farnesene (21)
(Scheme 3B). Due to the racemic nature of the starting diphos-
phate 11b it is, however, also possible that each enzymatic
product arises independently from the individual enantiomers.
GC–MS analysis of the organic soluble products generated
from an incubation of ADS with 12-methoxy-FDP (12)
revealed the formation of a 1:2.4 mixture of two sesquiter-
penoids of mass m/z 234 (Figure 3). Again, no organic soluble
products were detected when ADS was omitted from the incu-
bation mixture. The 1H NMR spectrum of this product mixture
(Figure 4) and comparison with the 1H NMR spectra of the
bisabolyl-derived sesquiterpenes β-sesquiphellandrene [38-40]
and zingiberene [40], a hydrocarbon with antifertility, antiviral
and anticancer activity [41], suggested that the major com-
pound was 12-methoxy-β-sesquiphellandrene (26), while the
minor product was identified as 12-methoxyzingiberene (27).
The two doublets observed at 0.85 and 0.87 ppm correspond to
the C14H3 groups for both compounds. The 13C-DEPT-135
spectrum (see Supporting Information File 1) showed an
inverted peak at ≈109 ppm, implying the presence of an olefinic
CH2 that couples to the two overlapped doublets at 4.74 ppm.
The integration of these doublets as 2 protons suggested that the
exocyclic alkene was present in only one of the products. In the
literature, this exocyclic alkene in β-sesquiphellandrene is ob-
served at 4.72 ppm as a multiplet [39]. A triplet at 5.39 ppm
that integrates for 2 protons can be assigned to H10 in both 26
and 27, which resonates further downfield than in β-sesquiphel-
landrene and zingiberene due to the methoxy group positioned
two carbons away. The olefinic protons H1 (δH = 5.67, d,
JH,H = 10.0 Hz) and H2 (δH = 6.14, d, JH,H = 10.0 Hz) of 26 are
in agreement with the equivalent protons H1 (δH = 5.66, dd,
JH,H = 10.0 and 2.5 Hz) and H2 (δH = 6.13, d, JH,H = 10.0 Hz)
in β-sesquiphellandrene. Similarly, the signals for the olefinic
protons H1 (δH = 5.63), H2 (δH = 5.77) and H4 (δH = 5.45) in
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Figure 3: Total-ion chromatogram of the pentane extractable products formed in an incubation of ADS with 12-methoxy-FDP (12). Inset: Mass spec-
tra of 26 and 27.
Figure 4: 1H NMR spectrum (400 MHz, CDCl3) of 12-methoxy-β-sesquiphellandrene (26) and 12-methoxyzingiberene (27) produced by ADS from
12-methoxy-FDP (12).
27 correspond to the equivalent protons (δH = 5.61), H2
(δH = 5.57) and H4 (δH = 5.42) in zingiberene [40].
Mechanistically, isomerisation of 12 to the methoxy-NDP ana-
logue 28 allows for an ADS-catalysed 1,6-cyclisation to the
12-methoxy-bisabolyl cation (29) followed by a [1,3]-hydride
shift, which relocates the positive charge on C1 in 30. With
FDP and 12-hydroxy-FDP, a subsequent 1,10-ring closure has
been proposed previously [29]. However, the presence of
monocyclic products indicates that this second ring closure does
not occur with 12-methoxy-FDP (12).
It is suggested that the 12-methoxy group enforces an orienta-
tion of the distal 10,11-double bond that is not conducive to the
Beilstein J. Org. Chem. 2019, 15, 2184–2190.
2189
Scheme 4: Possible mechanisms for the ADS-catalysed conversion of 12-methoxy-FDP (12) to 12-methoxy-β-sesquiphellandrene (26) and
12-methoxyzingiberene (27).
second ring closure. Subsequent deprotonation from C15 and
C4 from intermediate 30 affords 12-methoxy-β-sesquiphellan-
drene (26) and 12-methoxyzingiberene (27), respectively
(Scheme 4).
Conclusion
In conclusion, the class I sesquiterpene cyclase amorphadiene
synthase facilitates the efficient conversion of readily acces-
sible synthetic methoxy-FDPs to sesquiterpenoids that may
have applications in healthcare and agriculture. These results
inform us of both the utility and limitations that non-natural
functional groups have upon terpene cyclase-catalysed reaction
cascades supporting the design of future biocatalytic syntheses.
In particular, the presence of an ethereal oxygen atom contain-
ing π-acid functionality alongside its inductive withdrawal
effect has a profound effect on the carbocationic reactivity of
the intermediates. Of course a fully comprehensive interpreta-
tion of these results, regarding potentially interesting aspects
such as anchimeric assistance is hampered by unknowns such as
the conformation of binding to the enzyme and what effect the
extra bulk of the substituents has upon the results observed, but
nevertheless such empirical results will accumulate to inform
future investigations. This reversal of the biosynthetic reaction
order is expandable to other terpene synthases to generate
libraries of unnatural sesquiterpenoids with a wide range of
potential uses and applications across many areas of human ac-
tivity.
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